Increased GALNT10 expression also promotes tumor growth by creating an immunosuppressive microenvironment and is associated with poor clinical outcomes in those with high-grade ovarian serous carcinoma [61]. The gene discussed is GALNT10; the disease is ovarian serous carcinoma.